Skip to main content
SpringerLink
Log in

Optimization of the Use of Biological Samples for the Prospective Evaluation of Preneoplastic Lesions: Summary of Breakout Session

  • Chapter
Clinical and Biological Basis of Lung Cancer Prevention

Part of the book series: Respiratory Pharmacology and Pharmacotherapy ((RPP))

  • 81 Accesses

Abstract

The participants in this joint session had a wide-ranging discussion about these issues and came up with specific recommendations, since sample availability is such a major issue of prospective evaluation. Questions discussed included:

  1. 1.

    What truly constitutes a neuroendocrine tumor?

  2. 2.

    What events characterize distal preneoplasias?

  3. 3.

    Is there a precursor lesion for small cell lung cancer?

  4. 4.

    What are the best markers to use for preneoplasias, especially considering the limited materials available?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

  1. Thoracic Survery, Royal Brompton Hospital, London, UK

    R. Gemmill, Elisabeth Brambilla, J. P. Martin & Ugo Pastorino

Authors
  1. R. Gemmill
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elisabeth Brambilla
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. P. Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ugo Pastorino
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Hôpital de Brabois Service de Pneumologie A, Centre Hospitalier Universitaire de Nancy, 54511, Vandoeuvre-lès-Nancy, France

    Yves Martinet

  2. The Finsen Center Department of Oncology 5074, Copenhagen University Hospital Rigshospitalet, DK-2100, Copenhagen, Denmark

    Fred R. Hirsch

  3. Unité de Recherche de Physipathologie Respiratoire, INSERM U14, C.O. No 10, 54511, Vandoeuvre-lès-Nancy, France

    Nadine Martinet

  4. Service d’Anatomie Pathologique, Centre Hospitalier Universitaire de Nancy Hôpital Central, 54035, Nancy, France

    Jean-Michel Vignaud

  5. National Cancer Institute / National Institutes of Health, Division of Clinical Sciences / Medicine Branch Cell and Cancer Biology Department, Rockville, MD, 20850-3300, USA

    James L. Mulshine

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Basel AG

About this chapter

Cite this chapter

Gemmill, R., Brambilla, E., Martin, J.P., Pastorino, U. (1998). Optimization of the Use of Biological Samples for the Prospective Evaluation of Preneoplastic Lesions: Summary of Breakout Session. In: Martinet, Y., Hirsch, F.R., Martinet, N., Vignaud, JM., Mulshine, J.L. (eds) Clinical and Biological Basis of Lung Cancer Prevention. Respiratory Pharmacology and Pharmacotherapy. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-8924-7_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-0348-8924-7_30

  • Publisher Name: Birkhäuser, Basel

  • Print ISBN: 978-3-0348-9829-4

  • Online ISBN: 978-3-0348-8924-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation